Evidence map›Paper›PMID 25919393›Full record

ArticlePloS one2014

Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences.

Emily M Eriksson, Teri Liegler, Chris E Keh, Annika C Karlsson, Sara J Holditch, Christopher D Pilcher, Lisa Loeb, Douglas F Nixon, Frederick M Hecht

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Emily M ErikssonDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco Positive Health Program, San Francisco General Hospital, San Francisco, California.
Teri LieglerDepartment of Medicine, University of California, San Francisco Positive Health Program, San Francisco General Hospital, San Francisco, California.
Chris E KehDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco Positive Health Program, San Francisco General Hospital, San Francisco, California.
Annika C KarlssonDepartment of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.
Sara J HolditchDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco Positive Health Program, San Francisco General Hospital, San Francisco, California.
Christopher D PilcherDepartment of Medicine, University of California, San Francisco Positive Health Program, San Francisco General Hospital, San Francisco, California.
Lisa LoebDepartment of Medicine, University of California, San Francisco Positive Health Program, San Francisco General Hospital, San Francisco, California.
Douglas F NixonDivision of Experimental Medicine, Department of Medicine, University of California, San Francisco Positive Health Program, San Francisco General Hospital, San Francisco, California.
Frederick M HechtDepartment of Medicine, University of California, San Francisco Positive Health Program, San Francisco General Hospital, San Francisco, California.
San Francisco General Hospital · USUniversity of California, San Francisco · USKarolinska Institutet · SE

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Transmission and Persistence of CTL and Drug Resistance MutationsP01AI071713 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HECHT, FREDERICK M · 2007 to 2011
$14.3M
Training in HIV Translational ResearchT32AI060530 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Diane V Havlir · 2005 to 2026
$6.4M
Mentoring and Research in Integrative MedicineK24AT007827 · NCCIH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HECHT, FREDERICK M · 2013 to 2022
$1.8M
NCCIH NIH HHS K24 AT007827NIAID NIH HHS AI060530NIAID NIH HHS P01 AI071713NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI27763NIAID NIH HHS T32 AI060530
6 · The paper itself

Abstract

CD8+ T cells are important for HIV-1 virus control, but are also a major contributing factor that drives HIV-1 virus sequence evolution. Although HIV-1 cytotoxic T cell (CTL) escape mutations are a common aspect during HIV-1 infection, less is known about the importance of T cell pressure in reversing HIV-1 virus back to a consensus sequences. In this study we aimed to assess the frequency with which reversion of transmitted mutations in T cell epitopes were associated with T cell responses to the mutation. This study included 14 HIV-1 transmission pairs consisting of a 'source' (virus-donor) and a 'recipient' (newly infected individual). Non-consensus B sequence amino acids (mutations) in T cell epitopes in HIV-1 gag regions p17, p24, p2 and p7 were identified in each pair and transmission of mutations to the recipient was verified with population viral sequencing. Longitudinal analyses of the recipient's viral sequence were used to identify whether reversion of mutations back to the consensus B sequence occurred. Autologous 12-mer peptides overlapping by 11 were synthesized, representing the sequence region surrounding each reversion and longitudinal analysis of T cell responses to source-derived mutated and reverted epitopes were assessed. We demonstrated that mutations in the source were frequently transmitted to the new host and on an average 17 percent of mutated epitopes reverted to consensus sequence in the recipient. T cell responses to these mutated epitopes were detected in 7 of the 14 recipients in whom reversion occurred. Overall, these findings indicate that transmitted non-consensus B epitopes are frequently immunogenic in HLA-mismatched recipients and new T cell pressures to T cell escape mutations following transmission play a significant role in maintaining consensus HIV-1 sequences.

Indexed as

MutationCD8-Positive T-LymphocytesConsensus SequenceEpitopes, T-LymphocyteEvolution, Moleculargag Gene Products, Human Immunodeficiency VirusHIV-1HIV InfectionsHumansRNA, ViralSequence Analysis, RNAT-Lymphocytes, CytotoxicEpitopes, T-Lymphocytegag Gene Products, Human Immunodeficiency VirusRNA, Viral

Identifiers

PMID25919393
PMCPMC4412704
OpenAlexW2059979029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.